AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2235230
Drug: Surfactant (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant (100 mg of phospholipid per kilogram of body weight)
Trial: 843188
Drug: Rapid withdrawal
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid withdrawal at a rate of 10% of initial dose per week
Trial: 843188
Drug: Gradual withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gradual withdrawal at a rate of 3% of initial dose per week
Trial: 22590935
Drug: Glucose group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose group receiving acetated Ringer's solution containing 1% glucose (n = 10)
Trial: 22590935
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving acetated Ringer's solution without glucose (n = 10)
Trial: 15876901
Drug: Buspirone 30
RxNorm normalized name: busPIRone 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone 30 mg daily
Trial: 15876901
Drug: Buspirone 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone 45 mg daily
Trial: 15876901
Drug: Methadone taper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone taper
Trial: 9058493
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (TTS 50, 50 micrograms/die)
Trial: 9058493
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (CEE, 0.625 mg/die)
Trial: 3017401
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg once daily for 5 days
Trial: 3017401
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg once daily for 10 days
Trial: 25454414
Drug: FOLFIRI.3 (irinotecan,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) alternating with fixed-dose rate gemcitabine
Trial: 25454414
Drug: Fixed-dose rate
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose rate gemcitabine alone
Trial: 21415284
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate 1200 mg
Trial: 19243424
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate 400 mg
Trial: 18403189
Drug: 1.8 g
RxNorm normalized name: Calciquid, 1.8 g/5 mL oral syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g eicosapentaenoic acid (EPA) plus 0.3 g docosahexaenoic acid (DHA) per day for 8 weeks
Trial: 11239530
Drug: Diane 35
RxNorm normalized name: Dianeal PD-2/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diane 35 (2 mg of cyproterone acetate and 35 microg of ethinyl estradiol)
Trial: 11239530
Drug: Diane 35
RxNorm normalized name: Dianeal PD-2/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diane 35 plus finasteride (5 mg daily)
Trial: 9895419
Drug: GOS (galacto-oligosaccharides)
RxNorm normalized name: Go-dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GOS (galacto-oligosaccharides) 9 g daily
Trial: 9895419
Drug: Control (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (2 control yoghurts daily)
Trial: 3051991
Drug: Diltiazem (sustained-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (sustained-release preparation, titrated from 240 to 360 mg/day in a twice-daily regimen)
Trial: 101315
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered sodium cromoglycate (400 mg to 600 mg, four times daily)
Trial: 30614138
Drug: Low-flow induction
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flow induction (Group L)
Trial: 23537605
Drug: Community Treatment
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL LIQUID [Sanitizing Liquid for Community Support]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community Treatment Orders (CTOs)
Trial: 21817820
Drug: HES 130/0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HES 130/0.4 (≤ 30 ml/kg) followed by crystalloid infusion
Trial: 15234290
Drug: Deferred-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred-treatment group
Trial: 15234290
Drug: Immediate-treatment group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-treatment group
Trial: 9741505
Drug: Time from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time from symptom onset to treatment
Trial: 6348714
Drug: Flurbiprofen 50
RxNorm normalized name: flurbiprofen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 50 mg
Trial: 3072354
Drug: Acetaminophen 650
RxNorm normalized name: acetaminophen 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 650 mg plus codeine 60 mg
Trial: 1378147
Drug: Carvedilol 50
RxNorm normalized name: carvedilol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 50 mg
Trial: 21129866
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and intravenous bisphosphonates
Trial: 19268266
Drug: Diosmectite (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diosmectite (6 g/day for children 1-12 months; 12 g/day for children 13-36 months)
Trial: 17316925
Drug: WHO 17D-213/77
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHO 17D-213/77 vaccine
Trial: 17316925
Drug: Simultaneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous administration of yellow fever and measles-mumps-rubella vaccines
Trial: 27838777
Drug: Auranofin 6
RxNorm normalized name: Auranofin
DrugBank: Auranofin (DB00995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Auranofin 6 mg orally on day #2 of the chemotherapy cycle (post-paclitaxel)
Trial: 15579782
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg androstenedione t.i.d. for 28 days
Trial: 2946277
Drug: 3 monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 3 monthly doses of 2 micrograms vaccine mixed with adjuvant subcutaneously (Institut Pasteur Production‐Hevac B)
Trial: 2946277
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of 2 micrograms non‐adjuvated vaccine intradermally given 1 month apart
Trial: 24387842
Drug: Novamin 18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novamin 18 AAs (2 mL/kg/h)
Trial: 24387842
Drug: Pethidine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine (0.5 mg/kg)
Trial: 18496149
Drug: Tramadol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (1 mg/kg)
Trial: 19631856
Drug: Treatment delivered
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment delivered after occurrence of dental trauma
Trial: 17435407
Drug: Skin rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin rehabilitation massage therapy (SRMT) for 3 months
Trial: 17435407
Drug: Skin rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin rehabilitation massage therapy (SRMT)
Trial: 29923299
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg daily for 3 days
Trial: 20030435
Drug: Hylan G-F
RxNorm normalized name: hylan G-F 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hylan G-F 20 single-injection formulation
Trial: 18930254
Drug: Lycopene supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene supplement
Trial: 14654762
Drug: Diuretic-based regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic-based regimen (usually bendroflumethiazide)
Trial: 14654762
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor regimen (usually lisinopril)
Trial: 14654762
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (combined diuretic and ACE inhibitor)
Trial: 11127968
Drug: Vitamin A;
RxNorm normalized name: Acai Palm/Amylase/Amyloglucosidase/Apple/Ascorbic Acid/Banana/Beet/Beta-Fructofuranosidase/Black Currant/Blackberry/Blueberry/Cellulase/Cherry/Cranberry/Cyanocobalamin/Elderberry/Folic Acid/Goji/Grape/Hemicellulase/Lactobacillus Acidophilus/Lemon/Lipase/Mango/Noni/Orange/Papaya/Peach/Pectinase/Phytase/Pineapple/Plum/Pomegranate/Protease/Prune/Pyridoxine/Raspberry/Strawberry/Vitamin A;Amylase/Amyloglucosidase/Barley Grass/Beet/Bell Pepper/Beta-Fructofuranosidase/Broccoli/Cabbage/Carrot/Cellulase/Collard Green/Couch Grass/Folic Acid/Garlic/Ginger Root/Hemicellulase/Kale/Kelp/Lipase/Maitake Mushroom/Oat Bran/Onion/Parsley/Pectinase/Phytase/Protease/Pumpkin/Selenium/Spinach/Spirulina/Sweet Potato/Tomato/Turmeric/Vitamin A/Vitamin E 50 MG-50 MCG-60 MCG-100 MILLION CFU-2.5 MG-375 MCG; 140 MCG-100 MCG-375 MCG-10 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A; specific dosage and duration not available
Trial: 24368725
Drug: 3‐day intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3‐day intravenous infusion of creatine phosphate (CP) after PCI
Trial: 23734858
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional behavioral treatment (NT) for 16 weeks
Trial: 16584506
Drug: Cabergoline therapy
RxNorm normalized name: Cabergoline
DrugBank: Cabergoline (DB00248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cabergoline therapy (0.5-1 mg twice per week) for 12 weeks
Trial: 11038977
Drug: Drugs for
RxNorm normalized name: DRUGS FOR CONSTIPATION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs for nourishing the kidney‐yin, invigorating blood circulation and removing blood stasis
Trial: 11038977
Drug: Euglucon and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euglucon and other routine drugs
Trial: 3948126
Drug: Rubidazone 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rubidazone 450 mg/m2
Trial: 3948126
Drug: Rubidazone 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rubidazone 300 mg/m2
Trial: 24531549
Drug: Buspirone (serotonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (serotonin receptor type 1A agonist) prior to levodopa administration
Trial: 24531549
Drug: Levodopa (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa (identical doses)
Trial: 18702965
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (rosuvastatin 10 or 20 mg, atorvastatin 10 or 20 mg, simvastatin 20 or 40 mg)
Trial: 15936647
Drug: Black currant
RxNorm normalized name: Black currant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black currant seed oil (3 g/day)
Trial: 15936647
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2.8 g/day)
Trial: 11228758
Drug: Metformin (M)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (M) and Glibenclamide (G)
Trial: 11228758
Drug: Proinsulin change
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proinsulin change after therapy
Trial: 8759264
Drug: Sublingual timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sublingual timolol
Trial: 1930769
Drug: Carbachol exposure
RxNorm normalized name: Carbachol
DrugBank: Carbamoylcholine (DB00411)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbachol exposure (10 mg/mL) after nitrogen dioxide exposure
Trial: 1930769
Drug: Carbachol exposure
RxNorm normalized name: Carbachol
DrugBank: Carbamoylcholine (DB00411)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbachol exposure (10 mg/mL) after air exposure
Trial: 6627695
Drug: Metoclopramide, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide, 30 mg daily
Trial: 30113395
Drug: Norepinephrine (NE)
DrugBank: Norepinephrine (DB00368)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norepinephrine (NE) 6 µg
Trial: 30113395
Drug: Phenylephrine (PE)
DrugBank: Phenylephrine (DB00388)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylephrine (PE) 100 µg
Trial: 29764293
Drug: Biological educational
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological educational intervention
Trial: 24666617
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (dAPT) - clopidogrel (75 mg) plus aspirin (300 mg)
Trial: 24666617
Drug: Aspirin-monotherapy (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin-monotherapy (300 mg)
Trial: 24666617
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (dAPT)
Trial: 9699192
Drug: Preparation intervention
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation intervention (health education sessions)
Trial: 9699192
Drug: Preparation intervention
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation intervention
Trial: 7908610
Drug: Bucindolol 200
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 200 mg/d (high dose)
Trial: 7908610
Drug: Bucindolol 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 12.5 mg/d (low dose)
Trial: 7908610
Drug: Bucindolol 50
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 50 mg/d (medium dose)
Trial: 3171039
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for isolated systolic hypertension
Trial: 21907780
Drug: ModraDoc001 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ModraDoc001 15 mg capsules
Trial: 21907780
Drug: docetaxel premix
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel premix solution (TAXOTERE)
Trial: 12642306
Drug: Single lyophilisate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single lyophilisate (204 mg)
Trial: 12642306
Drug: Three conventional
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three conventional eye drops (40 ml fluorescein SE Thilo 0.17%)
Trial: 10673700
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg LSF
Trial: 10673700
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg LSF
Trial: 9266139
Drug: Monoclonal antibodies
RxNorm normalized name: Monoclonal antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibodies to block TNF-alpha
Trial: 10652641
Drug: IL-1 receptor
RxNorm normalized name: IL-1 TRAP
DrugBank: Rilonacept (DB06372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-1 receptor antagonist
Trial: 9266139
Drug: Combination therapies
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapies with monoclonal antibodies and long-acting rheumatic drugs (e.g., methotrexate)
Trial: 8184764
Drug: Patients selected
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients selected for late ventricular enlargement (change in ED volume > 20 ml, n = 19)
Trial: 3513801
Drug: Indomethacin, 25
RxNorm normalized name: Indomethacin, 25 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin, 25 mg, four times a day during therapy
Trial: 3513801
Drug: Placebo, four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, four times a day during therapy
Trial: 30088841
Drug: Probiotic preparation
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic preparation containing Lactobacillus, Bifidobacterium, and Streptococcus spp., 2 capsules daily for 14 days
Trial: 30088841
Drug: Placebo, daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, daily for 14 days
Trial: 25802980
Drug: EPA (eicosapentaenoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA (eicosapentaenoic acid) 1060 mg day(‐1)
Trial: 25802980
Drug: DHA (docosahexaenoic
RxNorm normalized name: Atabex DHA (docosahexaenoic acid 250 MG / eicosapentaenoic acid 100 MG) Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (docosahexaenoic acid) 900 mg day(‐1)
Trial: 22738908
Drug: Imagery Rehearsal
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imagery Rehearsal Therapy
Trial: 17137468
Drug: Early Treatment
RxNorm normalized name: Clearly It!
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early Treatment
Trial: 12070645
Drug: ACD anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACD anticoagulant (group A)
Trial: 7705801
Drug: L‐alanyl‐L‐tyrosine (Ala‐Tyr)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐alanyl‐L‐tyrosine (Ala‐Tyr)
Trial: 7705801
Drug: glycyl‐L‐tyrosine (Gly‐Tyr)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glycyl‐L‐tyrosine (Gly‐Tyr)
Trial: 7705801
Drug: N‐acetyl‐L‐tyrosine (Nac‐Tyr)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N‐acetyl‐L‐tyrosine (Nac‐Tyr)
Trial: 28478214
Drug: 15% carbamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% carbamide peroxide gel in tray
Trial: 23351409
Drug: 500 mL
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mL low-calorie cranberry juice cocktail (CJC) per day for 4 weeks
Trial: 23351409
Drug: 500 mL
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mL placebo juice (PJ) per day for 4 weeks
Trial: 12891223
Drug: Rofecoxib (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (25 mg daily)
Trial: 15794388
Drug: LA 600
RxNorm normalized name: Stress Formula 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LA 600 mg twice a day
Trial: 15794388
Drug: LA 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LA 1200 mg once a day
Trial: 15794388
Drug: LA 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LA 1200 mg twice a day
Trial: 15794388
Drug: LA (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LA (all doses)
Trial: 10713866
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of Lem1 (natural compound from lemon oil)
Trial: 8547043
Drug: Laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser treatment (pulsed tunable dye laser)
Trial: 6255982
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of ACTH
Trial: 26441156
Drug: Second-generation antipsychotics
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotics
Trial: 31575006
Drug: Cold pack
RxNorm normalized name: CVS Cold Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold pack (gel ice) applied postoperatively (Group 3)
Trial: 17520860
Drug: 0.3 g
RxNorm normalized name: sorbitol 0.3 GM Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g x kg(‐1) NaHCO3
Trial: 17520860
Drug: 8 g
RxNorm normalized name: Theranost 68 Ga Rgd
DrugBank: NODAGA-THERANOST Ga-68 (DB16940)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 g NaCl (placebo)
Trial: 7521498
Drug: Aprotinin 7
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprotinin 7 mg/kg until the end of perfusion
Trial: 2631971
Drug: Biobehavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biobehavioral treatment (bed rest, compliance enhancement training, and individualized thermal biofeedback-assisted relaxation training)
Trial: 70924
Drug: 7.1 mg
RxNorm normalized name: papain 77.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.1 mg potassium dichromate
Trial: 31092077
Drug: Sequential embryo
RxNorm normalized name: human embryo tissue preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential embryo transfer on day 3 and day 5
Trial: 28761608
Drug: Having additional
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Having additional monthly income from family members
Trial: 19732095
Drug: Spironolactone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (300 mg)
Trial: 19549427
Drug: Loratadine/Montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine/Montelukast (10 mg/10 mg once-daily)
Trial: 19549427
Drug: Pseudoephedrine (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine (240 mg once-daily)